Grey Supply Semaglutide 10mg – 99% Purity Research Peptide

In the dynamic field of metabolic endocrinology, few synthetic compounds have commanded as much scientific attention as Semaglutide. Originally developed as a therapeutic agent, this glucagon-like peptide-1 (GLP-1) receptor agonist has subsequently become an indispensable tool for preclinical investigation. At Grey Supply, we are proud to offer Semaglutide 10mg in a lyophilized format, rigorously tested to guarantee 99% purity. Consequently, researchers worldwide rely on this peptide to explore glucose homeostasis, appetite regulation, and adipose tissue metabolism with exceptional reproducibility.

Nevertheless, sourcing research-grade peptides requires careful scrutiny of quality, documentation, and supply-chain integrity. Therefore, this comprehensive product description outlines every critical aspect of our Semaglutide offering from its mechanistic properties and storage requirements to its diverse applications in in vitro and in vivo models. Furthermore, we provide explicit handling instructions to preserve bioactivity and ensure that your experimental data remains uncompromised.

Chemical Identity and Mechanism of Action

Semaglutide is a 31-amino-acid peptide analogue of human GLP-1, modified at position 26 with a fatty acid side chain that facilitates strong albumin binding. This structural modification subsequently extends its half-life substantially, making it a potent and durable agonist at the GLP-1 receptor. When introduced into cell cultures or animal models, Semaglutide activates the cAMP-dependent signaling pathway. As a result, it stimulates glucose-dependent insulin secretion, suppresses glucagon release, and delays gastric emptying—all while acting centrally to reduce food intake.

For researchers investigating type 2 diabetes pathophysiology, our Semaglutide 10mg vial provides a standardized, high-purity agonist for receptor-binding assays, calcium mobilization studies, and downstream phospho-ERK quantification. Meanwhile, for obesity-focused laboratories, this peptide serves as a gold-standard comparator against novel GLP-1/GIP dual agonists. In addition, many neuroscientists now employ Semaglutide to map GLP-1 receptor distribution in the hypothalamus and brainstem, thereby unraveling the neural circuits that govern satiety and reward.

Product Specifications and Purity Verification

Every batch of Grey Supply Semaglutide undergoes rigorous quality control using HPLC and mass spectrometry. Our 99% purity specification is not merely a marketing claim; instead, it represents the actual chromatographic purity determined through independent third-party testing. Furthermore, each vial contains exactly 10mg of lyophilized peptide net weight, devoid of unnecessary bulking agents or stabilizers that could interfere with your assay systems.

The peptide sequence is provided in its acetate salt form, which optimizes solubility and stability during reconstitution. For comparison, many commercial suppliers offer lower-purity batches that introduce degradation peaks or residual solvents. However, our manufacturing process employs solid-phase synthesis with strict end-capping protocols, followed by preparative reverse-phase purification. Consequently, researchers consistently report minimal lot-to-lot variability, a critical requirement for longitudinal studies and dose-response curve generation.

Recommended Storage and Handling Protocols

To maintain the integrity of this research compound, proper storage is non-negotiable. Upon arrival, the lyophilized powder should be stored at -20°C, protected from light and moisture. Under these conditions, the peptide remains stable for at least 24 months. However, once you reconstitute the Semaglutide 10mg vial, the solution becomes more labile. Therefore, we recommend using sterile, endotoxin-free water for injection (or PBS at pH 7.4) as the reconstitution vehicle. Following dissolution, aliquot the solution into single-use tubes and store them at -80°C for long-term preservation; alternatively, you can keep them at -20°C for up to one month, provided you avoid repeated freeze-thaw cycles.

It is equally important to note that Semaglutide exhibits a tendency to aggregate at higher concentrations. Hence, we suggest reconstituting at a concentration of 1–2 mg/mL to maintain monodisperse peptide populations. For researchers employing microdialysis or continuous infusion models, dilution in isotonic saline is acceptable immediately before use. Despite its robust fatty-acid modification, the peptide remains susceptible to proteolytic degradation in serum-containing media; consequently, we advise adding protease inhibitors (e.g., aprotinin or DPP-IV inhibitors) to your incubation mixtures when performing extended kinetic studies.

Primary Research Applications

The utility of Semaglutide extends across a broad spectrum of experimental paradigms. First and foremost, it serves as a reference agonist in GLP-1 receptor pharmacology. For instance, scientists routinely use this peptide to calculate IC50 values for novel antagonists, to assess receptor internalization kinetics, and to evaluate biased signaling profiles. Secondly, in rodent models of diet-induced obesity, subcutaneous administration of Semaglutide at doses ranging from 10 to 100 μg/kg produces dose-dependent reductions in body weight and adiposity, while simultaneously improving glycemic parameters. Subsequently, these models have become standard platforms for testing adjuvant therapies.

Moreover, cancer researchers have recently turned to Semaglutide to investigate the role of GLP-1 receptors in pancreatic islet cell proliferation and apoptosis. Although the mitogenic effects of GLP-1 agonists remain controversial, our high-purity peptide enables clean mechanistic dissection without the confounding variables introduced by degradation products. In the field of cardiovascular research, Semaglutide likewise demonstrates utility in perfused heart models, where it exerts cardioprotective effects against ischemia-reperfusion injury a phenomenon that is currently under intense investigation.

Solubility, Compatibility, and Dosing Guidelines

Achieving optimal solubility is straightforward with Grey Supply Semaglutide. The peptide dissolves readily in water and dilute acidic buffers; however, we discourage the use of organic solvents (e.g., DMSO or ethanol) because they can disrupt the secondary structure and diminish receptor affinity. For in vivo applications, most researchers dilute the stock solution into sterile saline or 5% dextrose immediately prior to injection. To avoid precipitation at physiological pH, we recommend adjusting the final pH to 7.0–7.4 using a small volume of sodium bicarbonate.

Dosing strategies vary widely based on the study objective. For acute pancreatic perfusion experiments, a single bolus of 3 nM is often sufficient to elicit a robust insulinotropic response. Conversely, chronic subcutaneous infusion via osmotic minipumps (e.g., Alzet models) typically requires daily doses of 0.2–0.5 mg/kg in mice. Because the pharmacokinetics differ markedly between species, we always advise running a pilot dose-finding study before committing to large-scale cohorts. Furthermore, when combining Semaglutide with other metabolic agents (e.g., SGLT2 inhibitors or FGF21 analogues), test the mixture for chemical compatibility and stability over 24 hours at 37°C.

Quality Assurance and Documentation

Transparency forms the cornerstone of our service at Grey Supply. Therefore, every Semaglutide 10mg shipment includes a certificate of analysis (CoA) that reports the exact HPLC chromatogram, mass spectrometry confirmation, residual solvent content, and endotoxin levels (<1 EU/mg). Additionally, we provide a data sheet containing recommended reconstitution volumes, molarity calculations, and stability profiles under various storage conditions. This documentation satisfies the rigorous requirements of institutional animal care committees and granting agencies alike.

Our peptide synthesis adheres to Good Manufacturing Practices (GMP) guidelines, albeit with modifications tailored to research-grade products. We do not claim clinical or pharmaceutical compliance; instead, we emphasize batch-to-batch consistency and chemical identity. For labs operating under FDA-regulated IND-enabling studies, we offer scaled production with enhanced documentation upon request. Nevertheless, all batches remain available for independent third-party retesting a policy that underscores our commitment to scientific integrity.

Safety, Disposal, and Regulatory Disclaimer

Because this product is designated FOR RESEARCH USE ONLY , it is explicitly prohibited for human consumption, therapeutic application, or diagnostic use. Researchers must handle the lyophilized powder and reconstituted solutions using appropriate personal protective equipment (PPE), including nitrile gloves, safety goggles, and lab coats. In addition, all operations involving Semaglutide should be conducted inside a certified chemical fume hood or biosafety cabinet to minimize inhalation or dermal exposure.

Disposal of unused peptide and contaminated materials must comply with local institutional and environmental regulations. For most laboratories, deactivation via 10% bleach solution followed by incineration is the accepted method. We strongly discourage flushing concentrated peptide solutions down the drain. Should accidental exposure occur, consult your institutional safety officer immediately and refer to the safety data sheet (SDS) provided with your shipment.

Why Choose Grey Supply for Your Research Peptides?

The research peptide marketplace is saturated with suppliers offering variable quality and opaque sourcing. Grey Supply differentiates itself through three core pillars: rigorous analytical control, transparent customer communication, and reliable logistics. Our Semaglutide 10mg vials arrive in amber glass vials with tamper-evident seals, accompanied by desiccant and oxygen absorbers to ensure stability during transit. Furthermore, we maintain regional warehouses in North America and Europe, reducing lead times and minimizing temperature excursions during shipping.

We recognize that your experiments cannot afford delays or data contamination from impure reagents. Hence, we back every peptide with a replacement guarantee if the purity falls below the stated 99% threshold. Our technical support team composed of experienced peptide chemists s available via email and live chat to assist with reconstitution dilemmas, dilution calculations, or unexpected solubility issues. In addition, we offer bulk discounts for larger quantities (e.g., 50 mg, 100 mg) and custom synthesis options for side-chain modifications or fluorescent labeling.

Reconstitution Example and Calculation

For researchers new to GLP-1 peptides, here is a practical example: To achieve a stock concentration of 2 mg/mL, add exactly 5 mL of sterile water to the 10mg lyophilized powder. Swirl gently do not vortex until the solution clears completely. This stock can then be diluted to working concentrations for cell-based assays. For instance, adding 5 µL of the stock to 495 µL of assay buffer yields a 20 µg/mL working solution. Subsequently, serial dilutions in half-log increments will generate a comprehensive dose-response curve ranging from 0.1 nM to 100 nM.

It is worth noting that the peptide’s fatty acid moiety may cause slight opalescence at high concentrations; however, this does not indicate aggregation and does not impair bioactivity. If cloudiness persists after 10 minutes of gentle swirling, filter the solution through a 0.22 µm sterile filter never through a cellulose-based filter, as this can adsorb the peptide.

Current Research Trends and Future Directions

The scientific literature on Semaglutide continues to expand exponentially. Recent studies have explored its neuroprotective effects in Parkinson’s disease models, its anti-inflammatory properties in adipose tissue macrophages, and its potential to modulate hepatic de novo lipogenesis. Consequently, demand for high-purity Semaglutide 10mg has surged among interdisciplinary teams. At Grey Supply, we monitor these emerging trends and adjust our production schedules accordingly, ensuring that our inventory meets the evolving needs of the research community.

Simultaneously, comparative studies between Semaglutide and novel dual agonists (e.g., tirzepatide, retatrutide) require impeccable purity to draw meaningful conclusions. Our peptide eliminates the variable of impurities, allowing you to attribute observed effects solely to the molecular target. As the field moves toward personalized medicine and biomarker-driven trial design, having a reliable, standardized reference compound becomes non-negotiable.

 Ordering, Shipping, and Support

Placing an order with Grey Supply is streamlined through our secure online portal. Upon checkout, you can select your preferred shipping temperature bient, cold pack, or dry ice based on your geographic location and anticipated delivery time. All shipments include tracking information and real-time temperature monitoring for cold-chain orders. For international customers, we provide all necessary customs documentation, including harmonized tariff codes and material safety data sheets, to facilitate smooth border clearance.

Should you have any questions regarding the suitability of Semaglutide for your specific cell line or animal model, our scientific liaison team is ready to offer literature references and protocol suggestions. We also invite you to request a small sample for preliminary testing before committing to bulk purchases. In summary, Grey Supply is more than a vendor; we are a collaborative partner dedicated to advancing metabolic research through uncompromising quality.

Final Note: This product is supplied for laboratory research purposes exclusively. Not for human or veterinary use. Always consult your institutional review board (IRB) and animal welfare committee (IACUC) before initiating any in vivo studies. All data and claims presented herein are based on published literature and internal quality tests; individual results may vary depending on experimental conditions.